£7.8M
The London-based biotechnology firm raised the capital from backers including Cantos Ventures and Y Combinator.
Sixfold Bioscience develops programmable delivery systems for RNA therapeutics.
Sixfold Bioscience designs programmable drug delivery systems by combining advanced chemistry and computation. The company focuses on expanding RNA therapeutics beyond the liver.
George Foot
Founder and co-CEO
Perdrix Rosell
Co-founder
The London-based biotechnology firm raised the capital from backers including Cantos Ventures and Y Combinator.